These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21060283)

  • 21. Association of olanzapine-induced weight gain with an increase in body fat.
    Eder U; Mangweth B; Ebenbichler C; Weiss E; Hofer A; Hummer M; Kemmler G; Lechleitner M; Fleischhacker WW
    Am J Psychiatry; 2001 Oct; 158(10):1719-22. PubMed ID: 11579009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [-2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association].
    Mou XD; Zhang ZJ; Zhang XR; Shi JB; Sun J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):316-20. PubMed ID: 18460775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of abnormal correlation between leptin and the body mass index during first and second generation antipsychotic drug treatment.
    Peña R; Marquina D; Serrano A; Elfakih Y; de Baptista EA; Carrizo E; Fernández V; Valery L; Teneud L; Baptista T
    Schizophr Res; 2008 Dec; 106(2-3):315-9. PubMed ID: 18835519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of long-term treatment with antipsychotics on serum leptin levels.
    Herrán A; García-Unzueta MT; Amado JA; de La Maza MT; Alvarez C; Vázquez-Barquero JL
    Br J Psychiatry; 2001 Jul; 179():59-62. PubMed ID: 11435270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of serum ghrelin levels in patients treated with clozapine.
    Theisen FM; Gebhardt S; Brömel T; Otto B; Heldwein W; Heinzel-Gutenbrunner M; Krieg JC; Remschmidt H; Tschöp M; Hebebrand J
    J Neural Transm (Vienna); 2005 Oct; 112(10):1411-6. PubMed ID: 15959857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between weight gain and clinical improvement: is there a metabolic threshold for second generation antipsychotics?
    Sharma E; Rao NP; Venkatasubramanian G; Behere RV; Varambally S; Sivakumar PT; Gangadhar BN
    Psychiatry Res; 2011 Mar; 186(1):155. PubMed ID: 20691482
    [No Abstract]   [Full Text] [Related]  

  • 27. An open-label tolerability study of BL-1020 antipsychotic: a novel gamma aminobutyric acid ester of perphenazine.
    Anand R; Geffen Y; Vasile D; Dan I
    Clin Neuropharmacol; 2010; 33(6):297-302. PubMed ID: 20921890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis.
    Potvin S; Zhornitsky S; Stip E
    Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S26-34. PubMed ID: 25886677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid leptin elevation after initiation of olanzapine?
    Wang HC; Chen PS; Lee IH; Yang YK; Yeh TL; Lu RB
    Neuropsychobiology; 2006; 54(3):182-5. PubMed ID: 17314489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients.
    Arranz B; Rosel P; Ramírez N; Dueñas R; Fernández P; Sanchez JM; Navarro MA; San L
    J Clin Psychiatry; 2004 Oct; 65(10):1335-42. PubMed ID: 15491236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association study of energy homeostasis genes and antipsychotic-induced weight gain in patients with schizophrenia.
    Jassim G; Fernø J; Theisen FM; Haberhausen M; Christoforou A; Håvik B; Gebhardt S; Remschmidt H; Mehler-Wex C; Hebebrand J; Lehellard S; Steen VM
    Pharmacopsychiatry; 2011 Jan; 44(1):15-20. PubMed ID: 20821366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifying the risk of atypical antipsychotics in the treatment of juvenile-onset schizophrenia.
    Townsend L; Findling RL
    Expert Opin Pharmacother; 2010 Feb; 11(2):195-205. PubMed ID: 20088741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment.
    Monteleone P; Fabrazzo M; Tortorella A; La Pia S; Maj M
    J Clin Psychopharmacol; 2002 Aug; 22(4):424-6. PubMed ID: 12172344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is antipsychotic drug--induced weight gain associated with a favorable clinical response?
    Lamberti JS
    J Clin Psychiatry; 2000 Sep; 61(9):678. PubMed ID: 11030490
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment.
    Lee AH; Lange C; Ricken R; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2011 Jun; 31(3):334-6. PubMed ID: 21508862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symptomatic versus metabolic changes with pharmacotherapy of schizophrenia.
    Small JG; Klapper MH; Malloy FW; Medlock CE; Kellams JJ
    Schizophr Res; 2005 Jun; 75(2-3):449-51. PubMed ID: 15885537
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma leptin and antipsychotic-induced body weight gain.
    Monteleone P; Fabrazzo M; Maj M
    Neuropsychopharmacology; 2005 Sep; 30(9):1769; author reply 1770-1. PubMed ID: 16107790
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta-analysis.
    Ragguett RM; Hahn M; Messina G; Chieffi S; Monda M; De Luca V
    Hum Psychopharmacol; 2017 Nov; 32(6):. PubMed ID: 28980344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Irisin, Adiponectin and Leptin Levels in Patients with Schizophrenia.
    Erzin G; Topcuoglu C; Kotan VO; Bayram S; Fountoulakis K
    Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):163-169. PubMed ID: 29219062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum leptin levels increase rapidly after initiation of clozapine therapy.
    Brömel T; Blum WF; Ziegler A; Schulz E; Bender M; Fleischhaker C; Remschmidt H; Krieg JC; Hebebrand J
    Mol Psychiatry; 1998 Jan; 3(1):76-80. PubMed ID: 9491817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.